← Leaderboards
John Michael Ruppert
University Of Alabama At Birmingham
$5,190,544
Attributed
$5,190,544
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $573.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,190,544 · 5
By mechanism
R01$3,707,238 · 3
P50$1,433,306 · 1
R13$50,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Donald D Muccio$2,766,715
- Craig A Elmets$8,601,504
- Francois M Booyse$4,391,058
- Coral Lamartiniere$4,406,474
- Edlue M Tabengwa$608,060
Others in their field
Top investigators on “Oncogenes”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David Heimbrook · Leidos Biomedical Research, Inc.$73,747,183
- Scott W Lowe · Sloan-Kettering Inst Can Research$36,382,798
- John Blenis · Harvard University (Medical School)$29,103,255
- Andrea Califano · Columbia University Health Sciences$28,006,523
- Robert Neil Eisenman · Fred Hutchinson Cancer Research Center$27,166,845
Research focus
OncogenesTranscription FactorMalignant NeoplasmsTissuesOralStructureStaining MethodEpithelialProteinsIn VitroNotch ProteinMcf10a CellsCellsMammary GlandGenetically Modified AnimalsIn VivoPathway InteractionsEpithelial CellsGrowthNuclearAntibodiesBreastMouse ModelStains
Grant awards (20)
Trainee Symposium for IDeA state trainees$50,000
R13 · FY2025 · CA · contact PI
Breast Cancer Biomarkers in the KLF4 Signaling pathway$280,908
P50 · FY2011 · CA · contact PI
Klf4 in tumor initiation and maintenance of squamous cell carcinoma$270,000
R01 · FY2011 · CA · contact PI
Breast Cancer Biomarkers in the KLF4 Signaling pathway$295,593
P50 · FY2010 · CA · contact PI
Klf4 in tumor initiation and maintenance of squamous cell carcinoma$278,350
R01 · FY2010 · CA · contact PI
Breast Cancer Biomarkers in the KLF4 Signaling pathway$295,488
P50 · FY2009 · CA · contact PI
Klf4 in tumor initiation and maintenance of squamous cell carcinoma$278,350
R01 · FY2009 · CA · contact PI
Breast Cancer Biomarkers in the KLF4 Signaling pathway$279,310
P50 · FY2008 · CA · contact PI
Klf4 in tumor initiation and maintenance of squamous cell carcinoma$275,500
R01 · FY2008 · CA · contact PI
Breast Cancer Biomarkers in the KLF4 Signaling pathway$282,007
P50 · FY2007 · CA · contact PI
Klf4 in tumor initiation and maintenance of squamous cell carcinoma$275,500
R01 · FY2007 · CA · contact PI
Role of GLI in Tumor progression$252,035
R01 · FY2006 · CA · contact PI
Role of GLI in Tumor progression$258,100
R01 · FY2005 · CA
Role of GLI in Tumor progression$258,100
R01 · FY2004 · CA
ROLE OF GKLF IN EPITHELIAL DYSPLASIA$258,300
R01 · FY2003 · CA
Role of GLI in Tumor progression$258,100
R01 · FY2003 · CA
ROLE OF GKLF IN EPITHELIAL DYSPLASIA$258,300
R01 · FY2002 · CA
Role of GLI in Tumor progression$257,878
R01 · FY2002 · CA
ROLE OF GKLF IN EPITHELIAL DYSPLASIA$258,300
R01 · FY2001 · CA
ROLE OF GKLF IN EPITHELIAL DYSPLASIA$270,425
R01 · FY2000 · CA